Private equity firm Consonance Capital Partners (CCP) has held the final closing of its USD500 million healthcare private equity fund.
The fund was oversubscribed, surpassing its USD350 million target and reaching its fundraising cap of USD500 million.
Consonance Capital Partners invests in private companies in the lower middle market of the US healthcare industry with an emphasis on businesses driving efficiency, cost containment and high quality clinical care to patients.
CCP’s founders, Mitchell Blutt, Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle, partnered together for over a decade while at JPMorgan Partners and its successor and predecessor entities, and have over 65 years of combined experience in private equity investing, primarily within healthcare.
The private equity fund is associated with Consonance Capital Management, a healthcare-focused public equity manager with approximately USD600 million of assets under management.
“We are pleased to announce the final closing of our first private equity fund at a level that exceeded our target,” says Blutt, CEO of Consonance Capital. “We continue to extend our leading franchise within the healthcare investment community. This platform enables us to build on our practice of bringing to bear our industry expertise and resources to help management teams and businesses realise their full growth potential.”
Fri 23/12/2016 - 08:30
Wed 23/12/2015 - 08:00
Wed 23/07/2014 - 08:59
Mon 21/07/2014 - 14:40
Fri 18/07/2014 - 15:10
Thu 25/06/2015 - 10:40
Thu 15/01/2015 - 08:19
Wed 23/07/2014 - 12:01
Tue 22/07/2014 - 13:01
Tue 22/07/2014 - 12:06